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BACKGROUND  
Traditional catheter based treatment for atrial fibrillation 
(AF) uses radiofrequency as a source of energy for the 
ablation of atrial tissue.  This is an endocardial (inside the 
heart) technique.  The success rate of this technique at one 
year is around 50-60%
1
. In the last three years, a novel 
technology using a combined/hybrid trans-diaphragmatic 
surgical epicardial (outside the heart) ablation with 
endocardial (inside the heart) ablation techniques have had 
one-year success rates close to 80%
2
.  This is called the 
Convergent Procedure (CP) 
3
. The CP can be done with 
either radiofrequency ablation (RF), or with a cryo-balloon 
catheter to create the endocardial lesion set. The cryo-
balloon technique may be a preferred approach, as it 
creates improved endocardial coverage of the pulmonary 
veins. Limited data is available on the cryo-balloon 
technique for CP.  
 
OBJECTIVE 
To evaluate the effectiveness and patient outcomes of 
utilizing the cryo-balloon ablation technique in the setting 
of the Convergent Procedure(CP).  
 
METHODS 
From October 2013 to May 2015, thirty-one AF patients 
underwent the convergent procedure with cryo-balloon 
endocardial ablation at LVHN. Patients were managed 
postoperatively medically with amiodarone, steroids, 
anticoagulants, and anti-inflammatories. Follow-up visits 
occurred 1 month, 3 months, 6 months, and 12 months 
after the surgery. Most (89%) patients received an 
implantable monitoring device that was interrogated at 
each visit for arrhythmias.  
Medical records were reviewed to determine pre-
operative comorbidities and post-operative outcomes. 
Descriptive statistics were utilized to analyze the data.  
 
RESULTS 
Of the atrial fibrillation patients undergoing a convergent 
procedure with a cryo-balloon, 30% suffered from 
paroxysmal AF; 70% from persistent or chronic AF. 
Arrhythmia-free survival after the convergent procedure 
using a cryo-balloon catheter, including repeat ablation 
was 92% three months post-operatively and 89.5%  six 
months post-operatively. One patient required a repeat 
ablation post-operatively. There were no deaths. Major 
complications included one patient experiencing 
pericardial effusion and one with hemoperitoneum.  
 
CONCLUSIONS 
This study of 31 patients suggests that the use of a cyro-
balloon catheter for endocardial ablation during the 
convergent procedure is a viable method to eliminate the 
recurrence of persistent atrial fibrillation and arrhythmias. 
Further study is warranted that obtains a larger sample size 
of CP patients and allows more time between operation 
and follow-up data collection. Other data should be 
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ACRONYMS 
AF= Atrial fibrillation; CP= Convergent Procedure; RF= 
Radiofrequency; ACT= Activated clotting time 
Introduction 
Atrial fibrillation (AF) is the most common 
abnormal heart rhythm, effecting approximately 
2.2 million individuals in the United States4. AF 
can be treated medically, and/or by means of 
shocking the heart back into rhythm via 
cardioversion(s) and/or by ablating electrical 
tissue of the posterior heart. Patients with AF 
whom experience persistent symptoms even after 
receiving the above treatments are considered 
appropriate candidates for the hybrid 
epicardial/endocardial-ablating convergent 
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procedure (CP). Traditionally, ablations utilize 
radiofrequency (RF) energy as a means to 
cauterize the electrical tissue of the heart. The 
epicardial portion of the convergent procedure 
uses this such technique. However, for the 
second portion of the procedure, it may be more 
effective to utilize a cryo-balloon catheter to 
freeze the endocardial tissue rather than 
cauterizing it with a RF source. The endocardial 
segment of the CP is conducted by an 
electrophysiologist who feeds a catheter thru the 
femoral artery to the posterior aspect of the heart. 
The RF catheter tip requires approximately 30 
small burns around the pulmonary veins to 
isolate all electrical conduction that could disturb 
the heart’s sinus rhythm. The cryo-balloon 
catheter requires only 8-14 lesions to freeze the 
electrical tissue around the pulmonary veins.  
 
Figure 1: Radiofrequency Endocardial Ablation
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Figures 1 and 2 show cross sections of the heart exposing 
the left atrium and interior pulmonary vein ostia. The first 
figure depicts the radiofrequency circumferential mapping 
process while the second figure animates cryo-balloon 





Between October 2013 and May 2015, thirty-
seven AF patients underwent the convergent 
procedure at Lehigh Valley Hospital at Cedar 
Crest in Allentown, Pennsylvania. The cryo-
balloon technique was used on 31 of those 37 
patients to isolate the endocardium. RF ablations 
were applied to the other 6 patients. Patients met 
criteria to undergo the convergent procedure if 
they experienced symptomatic AF for an 
extended period of time, and/or if they had a 
history of failed medical therapies, 
cardioversions or traditional ablations for 
treatment of AF. Patients were excluded from the 
study if they were administered RF ablations 
during the endocardial portion of their CP. 
 
Ablation Procedure 
The Convergent Procedure is divided into two 
parts; epicardial and endocardial. The epicardial 
portion is performed by a cardiothoracic surgeon.  
To begin, general anesthesia is induced and 
maintained throughout the entire case. An 
esophageal temperature probe is placed and the 
patient is prepped and draped in the usual sterile 
fashion. A small incision is made in the midline, 
approximately 2 cm below the xiphoid process. 
The surgeon then enters the peritoneal cavity 
using a modified Hassan technique. Two 
additional 5-mm trocars are placed in the 
midclavicular line, on either side. This is done 
under direct palpation. The abdomen is then 
insufflated with carbon dioxide to achieve a 
pneumoperitoneum. The surgeon identifies the 
falicform ligament and creates a pericardial 
window in the central tendon of the diaphragm. 
Next, the surgeon guides the nContact cannula 
into the pericardial space and removes the 5-mm 
trocars. The posterior aspect of the left atrium is 
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then ablated with a radiofrequency device for 90 
seconds per ablation in a linear fashion from the 
left pulmonary veins to the right pulmonary 
veins. A double lesion set is created. The 
nContact cannula is then flipped to access and 
ablate the anterior surface of the right and left 
pulmonary veins. Total lesions range from 16 to 
23. Finally, a drain is placed into the pericardial 
space and exited out one of the 5-mm trocar 
sites. The fascia and skin are repaired in the 
usual fashion. The case is then turned over to an 
electrophysiologist for the endocardial portion.  
 
The electrophysiologist begins by assuring the 
groin area is clipped, prepped and draped in the 
usual sterile fashion. Local anesthesia is applied 
to the groin and a transseptal catheterization is 
performed under fluoroscopic and hemodynamic 
guidance. A one-puncture transseptal access is 
performed using a Brockenbrough needle 
assembly with a long sheath. Once the catheter is 
across the atrial septum, heparin is immediately 
infused and dosed to maintain an activated 
clotting time (ACT) of > 300 seconds. CT levels 
are assessed every 15 minutes throughout the 
procedure. Next, right femoral vein access is 
obtained for catheter placement. The vessel is 
accessed using the modified Seldinger technique. 
Similarly, left femoral vein access is obtained for 
electrode placement. Then, right internal jugular 
vein access is obtained for coronary sinus 
catheter placement. Using an Intracardiac 
echocardiography (ICE), a catheter is then 
advanced into the right atrium. An 
echocardiography is used to guide the transseptal 
puncture, guide catheter positioning, measure the 
diameter of the pulmonary vein ostia, ensure 
proper contact between the ablation catheter and 
the endocardium, measure pulmonary venous 
blood flow velocity before and after ablation, 
and identify esophagus location relative to 
posterior left atrium. At the conclusion of the 
procedure, ICE imaging is used to ensure there is 
no evidence of pericardial effusion.  
After the catheter enters the right atrium, 
electrophysiologic testing is performed and 
measurements of basic intervals and refractory 
periods are obtained. Catheters are positioned in 
the high right atrium, right ventricular apex, left 
atrium and His-bundle region for pacing and 
recording. Arrhythmia induction 
protocols include programmed stimulation 
without acute drug testing. A shell of the 
pulmonary veins and the left atrium was made 
prior to surgery using the EnSite Velocity
10
 3-D 
mapping system. The anatomy of the pulmonary 
veins are determined in this manner. A 20mm 
Achieve circular mapping catheter is then 
positioned within each of the individual 
pulmonary vein ostia. Pulmonary vein potentials 
are determined in all four veins. The 
electrophysiologist ensures the occlusion of each 
pulmonary vein and then employs a “freeze-
thaw-freeze” strategy which ultimately delivers 
two lesions per vein. Occlusion is determined by 
repeat contrast pulmonary venography and lack 
of color flow via ICE imaging. The cryo-balloon 
is inflated with a liquid refrigerant (liquid 
nitrogen).  The refrigerant evaporates and scars 
the tissue of the occulted pulmonary vein, thus  
 
Figure 3: Cryo-balloon catheter
5                 
eliminating any electrical conduction that could 
interfere with electrical currents in the atria and 
cause atrial fibrillation
6
. The Arctic Front 
Advance 23mm or 28mm cyro-balloon ablation 
catheter is positioned at the ostium of the left 
superior pulmonary vein, left inferior pulmonary 
vein, right superior pulmonary vein and right 
inferior pulmonary vein. Each vein receives a 1 
to 3 lesions which results in the isolation of each 
respective vein.  The total lesion time ranges 
from 1353 to 2674 seconds.  
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Figure 4: Complete Pulmonary Vein Isolation 
 
This image depicts the shell of the pulmonary veins of a 
LVHN CP patient. The grey area represents electrical 
isolation on scarred tissue.  
 
Postoperative management 
Patients were restarted on their normal 
medication after the procedure. Additionally, at 
least 77% of the patients received the following 
medical therapy; an anticoagulant (heparin, 
coumadin, eliquis) and an anti-inflammatory 
(colchicine) administered 6-12 hours after the 
operation. An intravenous steroid (salumedrol; 
methoprednisolin) administered for 2-3 days 
post-operatively and amiodarone taken for 6-8 
weeks to manage lingering arrhythmias. To 
thoroughly record both asymptomatic and 
symptomatic arrhythmia episodes, 89% of the 
patients received remote monitoring devices 
(41% Lifewatch EM, 8 % ILR, 22% PPM-dual, 
7 % ICD-Dual 11% Holter, 11% None).  
 





Patients were seen in the office at 1 month, 3 
month, 6 month, and 12 month intervals when 
applicable. At each visit, monitoring devices 
were interrogated and/or echocardiograms were 
administered to determine heart rhythm.  
Recurrent arrhythmias were defined as episodes 
lasting greater than 1 minute or accounting for 
greater than a 2% burden as recorded by a 
monitoring device. Medications were also 






N = population size; SD = standard deviation; n= number; AF=  
atrial fibrillation; HD= heart disease 
 
The patients were between the ages of 40 and 81 
at the time of the procedure. The average age 
was 66 years old.  Male patients defined 67.5% 
of the study population. All patients were of 
white race. Patients had either paroxysmal, 
persistent, or longstanding persistent (chronic) 
AF. 
 
76.6% (23/30) of patients were in sinus rhythm 
at every follow up. At 3 months, 100% (26/26) 
of patients were free of atrial fibrillation while 
92% (23/25) of patients that received the full 
convergent procedure were arrhythmia-free. Six 














Table 1:  Study Population Demographics 
Characteristic Subjects 
N 31 
Age (years), mean (range) 66 (40-81)        
Sex:Male,  n (%) 23 (74.2) 
Paroxysmal AF, n (%) 9 (30) 
Persistent AF, n (%) 22 (70) 
Hypertension, n (%) 23 (74.2) 
Obesity, n (%)  8 (25.8) 
Congestive Heart Failure, n (%) 9 (29) 
Current/Past Tobacco Use, n (%) 14 (48.3) 
Sleep Apnea, n (%) 11 (34.4) 
Pacemaker, n (%) 7 (22.6) 
Previous Ablation, n (%) 13 (38.7) 
Previous Cardioversion, n (%) 17 (54.8) 
Family Hist. HD, n (%) 13 (43.3) 









patients were AF-free while 89.5% (17/19) were 
arrhythmia-free. Twelve month post-operative 
data was only available for 6 patients. All of 
these patients (100%) were arrhythmia and AF- 
free.  
 
Table 2: Post-operative outcomes 
 
 AF-free Arrhythmia-free 
3 months  100% 92% 
6 months 94.7% 89.5% 
12 months 100% 100% 
 
Heart rhythm was determined by interrogating 
monitoring devices and/or by administering 
echocardiograms. A total of 5 patients did 
experience recurrent arrhythmias after the 
convergent procedure using a cryo-balloon 
catheter. Three out of five experienced post-
operative recurrent atrial flutter and were 
cardioverted back into sinus rhythm. One of 
these three patients only received endocardial 
ablations due to liver adhesions, leaving the 
surgeon to abort the epicardial portion of the CP.  
One patient experienced symptomatic atrial 
tachycardia and received another traditional 
ablation along with cardioversions. One patient 
experienced irregular rhythm after an epicardial-
only ablation. This patient received endocardial 
ablation 3 months later, but did experienced 
recurrent atrial fibrillation without palpitations 
before returning to sinus rhythm. Overall, 3.2% 
(1/30) of patients required repeat ablation and 
12.9% (3/30) required post-operative 
cardioversion due to recurrent arrhythmias.  
 










Literature on the convergent or “hybrid ablation” 
procedure is heavily concentrated on 
radiofrequency ablation for both epicaridal and 
endocardial segments. A Polish study found 
72.2% (13/18) of their patients in sinus rhythm 6 
months after the procedure and 80% (8/10) in 
sinus rhythm after 12 months
2
. Civello, et al., 
reports 89% of their patients (93/104) in sinus 
rhythm approximately 6 months post- 
operatively
7
.  Gehi, et al., reports a 12-month 
arrhythmia free survival of 70.5% and a repeat 
ablation rate of 6%
3
.   
 
Traditional radiofrequency catheter ablation 
alone has much lower success rates. A 43 patient 
study reports 56.5% in normal sinus rhythm 
using antiarrhythmic drugs six months after the 
ablation
1 
. Another endocardial-only 
radiofrequency ablation study provides 12 month 




Figure 7: Success of Convergent Procedure using Cryo-






Overall, procedural complications were very 
limited. A total of two patients (6.4%) 
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Although several measures are taken to avoid 
effusion including administering anti-
inflammatory drugs, one patient experienced 
pleural effusion 4 days post-operatively. This 
patient required reoperation for drain insertion. 
He recovered and was discharged the next day. 
The other patient experienced hemoperitoneum 
with a hematoma around on the trocar sites 
secondary to their anticoagulated state following 
surgery. The patient was re-operated on and had 
hematomas evacuated with suction and 
controlled with cautery. The patient was 
discharged 4 days after the convergent procedure 
and recovered successfully. There were no 
procedural mortalities, no atrioesophogeal 











The study included only patients with 
symptomatic AF. This was a retrospective study 
of the effectiveness of cryo-balloon ablation for 
eliminating the recurrence of AF. No quality of 
life surveys were collected. A control group of 
RF ablations was not studied; rather the control 
group statistics were represented from previous 
literature. Furthermore, time posed a great 
limitation on this study as the convergent 
procedure has only been performed for two years 
in the Lehigh Valley Hospital. Many patients 
underwent their CP less than a year before the 
conduction of study. Thus, limited follow-up 




This retrospective review of a cohort of 31 
patients suggests that the use of a cyro-balloon 
catheter for endocardial ablation during the 
convergent procedure is a viable method to 
eliminate the recurrence of persistent atrial 
fibrillation and arrhythmias.  
 
A literature review of radiofrequency ablation 
convergent procedures offers success rates very 
close to the cryo-balloon rates described in this 
study. However, these studies contained a much 
larger sample size and occurred over a 
significantly longer time period. For this reason,  
further study is warranted that obtains a larger 
sample size of CP patients and allows more time 
for follow-up data collection.  
 
Other data should be collected on the time 
efficiency of the cryo-balloon versus 
radiofrequency technique. Because the RF 
catheter requires the electrophysiologist to 
administer more than 28 burns around the 
circumferences of each pulmonary vein, while 
the heart is beating, while the patient is 
breathing, it is difficult to ensure proper contact 
of catheter to tissue and to ensure equal distance 
between each burn so that the entirety of the 
tissue is electrically isolated. In comparsion, 
once a cryo-balloon is positioned in the opening 
of a pulmonary vein and occlusion is confirmed, 
it is inflated with liquid nitrogen one to three 
times. The use of a cryo-balloon catheter is 
simpler, faster and usually ensures complete 
electrical isolation with no missed tissue.  
 
The efficiency of the procedure can lead to more 
patients scheduled for operation, and better 
outcomes with greater quality of life overall.  
Additionally, lesser recurrence of arrhythmias 
correlates with lower costs for the patient and 
hospital. The more effective the convergent 
procedure, the lower amount of repeat ablations, 







Table 3: Major Complications 
N 31 
Procedural Mortality 0 
Atrioesophageal fistula 0 
Pericardial effusion 1 
Pericardial tamponade 0 
Bleeding 1 
Total  2 (6.4%) 
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